En el futuro, la importancia de los agonistas del GLP-1 y de los agonistas o poliagonistas duales del GLP1/GIP en el tratamiento de la obesidad seguir aumentando, afirma el Dr
Missing doses or taking your tablet at varying times delays the steady-state accumulation that drives results, potentially extending your timeline by several weeks
Notably, pharmacological blockade of opioid and benzodiazepine receptors partially reversed AST-mediated neuroprotection, suggesting that receptor-dependent mechanisms may contribute to its cognitive benefits beyond classical antioxidant activity (Rastinpour et al., 2025)
Cell 76(6):10251037 Dickinson SE, Melton TF, Olson ER, Zhang J, Saboda K, Bowden GT (2009) Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer